// App-Quantinova.ai

OA0145 : Characterization of amoxicillin‐ and clavulanic acid‐specific T‐cells in patients with amoxicillin‐clavulanic acid hypersensitivity reactions

Researchers

Presenter

  • Ariza Veguillas A

Principal Investigators

  • Salas M

  • Ogese MO

  • Montaez MI

  • Fernndez T

  • Mayorga C

  • Torres MJ

  • Naisbitt DJ

Medical Centers

  • Allergy Unit, IBIMA—Regional University Hospital of Malaga—University of Malaga, Málaga, Spain

  • Allergy Unit, IBIMA—Regional University Hospital of Malaga—University of Malaga, Málaga, Spain

  • Dept. Molecular & Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom

  • BIONAND, Malaga, Spain

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • Amoclan suspension

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A